Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
12
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Childhood Leukemia 2017 NCI 5R01CA181050-04 KIR-FAVORABLE HAPLOIDENTICAL TRANSPLANTATION IN CHILDREN PULSIPHER, MICHAEL CHILDREN'S HOSPITAL OF LOS ANGELES CA $90,772
Childhood Leukemia 2017 NCI 5R21CA187412-03 Impact of primary tumor development stage on prognosis and outcome in B-ALL CARLSON, CHRISTOPHER FRED HUTCHINSON CANCER RESEARCH CENTER WA $100,931
Childhood Leukemia 2017 NIEHS 5U13ES026496-02 Childhood Leukemia International Consortium Scientific Annual Meetings METAYER, CATHERINE UNIVERSITY OF CALIFORNIA BERKELEY CA $15,000
Childhood Leukemia 2017 NCI 5R01CA132640-16 Role of heat shock factors (Hsfs) in tumorigenesis MIVECHI, NAHID AUGUSTA UNIVERSITY GA $270,000
Childhood Leukemia 2017 NCI 5R01CA190964-03 Role of IKAROS in the Biology and Therapy of High-Risk Precursor B-Cell Leukemia VAN ETTEN, RICHARD UNIVERSITY OF CALIFORNIA-IRVINE CA $544,106
Childhood Leukemia 2017 NCI 5R01CA191077-03 Assay Development for NSD1 Methyltransferase Inhibitor Discovery KOLB, EDWARD ALFRED I. DU PONT HOSP FOR CHILDREN DE $312,244
Childhood Leukemia 2017 NCI 5R21CA195356-02 Role of ThPOK in HSC Maintenance and Leukemogenesis KAPPES, DIETMAR RESEARCH INST OF FOX CHASE CAN CTR PA $199,013
Childhood Leukemia 2017 NCI 5R21CA194829-03 Metabolic regulation of T-ALL cellular proliferation and lifespan RATHMELL, JEFFREY VANDERBILT UNIVERSITY MEDICAL CENTER TN $204,885
Childhood Leukemia 2017 NCI 1R35CA197695-01A1 Translating genomic discoveries to improved outcomes for high risk acute leukemia MULLIGHAN, CHARLES ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $1,071,276
Childhood Leukemia 2017 NCI 5R01CA195519-02 Image-guided irradiation safely intensifies HSCT regimen for refractory leukemia FORMAN, STEPHEN BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $272,213
Childhood Leukemia 2017 NCI 5R01CA201184-02 Biologic and Therapeutic Significance of miR-155 in AML MARCUCCI, GUIDO BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $554,107
Childhood Leukemia 2017 NCI 5R01CA072669-20 Cytotoxic-T-Lymphocyte (CTL) Therapy of AML BLAZAR, BRUCE UNIVERSITY OF MINNESOTA MN $294,076
Childhood Leukemia 2017 NCI 5R01CA169784-04 Genetic Dissection of Acute Myeloid Leukemia. AIFANTIS, IANNIS NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $355,993
Childhood Leukemia 2017 NCI 5R01CA172408-04 Role of Asxl1 in normal hematopoiesis and pathogenesis of myeloid malignancies YANG, FENG-CHUN UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $318,513
Childhood Leukemia 2017 NCI 5R01CA174683-04 Comprehensive Approach to Improve Medicine Adherence in Pediatric Leukmia BHATIA, SMITA UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $606,475
Childhood Leukemia 2017 NCI 5R01CA182528-05 Potential therapeutic implications of targeting miR-150 in acute myeloid leukemia CHEN, JIANJUN UNIVERSITY OF CINCINNATI OH $336,114
Childhood Leukemia 2017 NCI 5R00CA181500-04 The Role of Protein Tyrosine Phosphate PRL3 in Leukemia Development BLACKBURN, JESSICA UNIVERSITY OF KENTUCKY KY $248,999
Childhood Leukemia 2017 NCI 5F31CA196330-02 Investigating the potential role of NADPH oxidase 2 in regulating the biology of leukemic stem cells ADANE, BINIAM UNIVERSITY OF COLORADO DENVER CO $29,728
Childhood Leukemia 2017 NHLBI 5R01HL117976-04 Epithelial mechanisms of inducible resistance to AML-associated pneumonia EVANS, SCOTT UNIVERSITY OF TX MD ANDERSON CAN CTR TX $400,000
Childhood Leukemia 2017 NCI 5R01CA167708-05 Targeting AML with PI3K/AKT inhibitors and BH3-mimetics GRANT, STEVEN VIRGINIA COMMONWEALTH UNIVERSITY VA $284,794
Childhood Leukemia 2017 NCI 5R01CA194058-02 Painted erythrocyte carriers for therapy of acute myeloid leukemia SIMBERG, DIMITRI UNIVERSITY OF COLORADO DENVER CO $352,151
Childhood Leukemia 2017 NCI 5R01CA185301-03 Enhancing NK Cell Activity by Dietary Diphyllin Lignans for Cancer Prevention CALIGIURI, MICHAEL OHIO STATE UNIVERSITY OH $352,275
Childhood Leukemia 2017 NCI 5R01CA201230-02 The role of H3K79 methylation in IDH-mutant leukemia BERNT, KATHRIN UNIVERSITY OF COLORADO DENVER CO $10,000
Childhood Leukemia 2017 NCI 5R01CA090668-14 FLT3 Tyrosine Kinase Inhibitors as Therapy for Leukemia SMALL, DONALD JOHNS HOPKINS UNIVERSITY MD $291,600
Childhood Leukemia 2017 NCI 5R01CA142665-07 Glucocorticoids in Lymphoblastic Leukemia RELLING, MARY ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $487,994
Childhood Leukemia 2017 NCI 5K08CA181340-04 Targeting Chromatin Modifications in Leukemia with Trisomy 21 LANE, ANDREW DANA-FARBER CANCER INST MA $155,991
Childhood Leukemia 2017 NHLBI 5R01HL130034-02 The Cebpa Enhancer in Normal Hematopoiesis and Progression to AML FRIEDMAN, ALAN JOHNS HOPKINS UNIVERSITY MD $405,000
Childhood Leukemia 2017 NCI 5F30CA183507-04 Cytotoxicity of MLN4924 in Acute Myeloid Leukemia KNORR, KATHERINE MAYO CLINIC ROCHESTER MN $23,878
Childhood Leukemia 2017 NCI 5R01CA172398-05 The role of ETV6 in T-cell acute lymphoblastic leukemia FERRANDO, ADOLFO COLUMBIA UNIVERSITY HEALTH SCIENCES NY $332,000
Childhood Leukemia 2017 NCI 5R21CA183623-03 Pediatric Cancer Salvia Biorepository GRAHAM, DAVID JOHNS HOPKINS UNIVERSITY MD $245,885
Childhood Leukemia 2017 NCI 5R01CA173636-05 Role of TET2 mutations in malignant transformation and acute myeloid leukemia LEVINE, ROSS SLOAN-KETTERING INST CAN RESEARCH NY $639,626
Childhood Leukemia 2017 NCI 5F30CA183497-04 Modeling Transformation: Myeloproliferative Neoplasms to Acute Myeloid Leukemia MCKENNEY, ANNA WEILL MEDICAL COLL OF CORNELL UNIV NY $49,044
Childhood Leukemia 2017 NCI 5R01CA172268-05 The role of inhibitory receptors in leukemia development ZHANG, CHENGCHENG UT SOUTHWESTERN MEDICAL CENTER TX $329,925
Childhood Leukemia 2017 NCI 5R01CA201225-02 Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy ARMISTEAD, PAUL UNIV OF NORTH CAROLINA CHAPEL HILL NC $500,397
Childhood Leukemia 2017 NCI 2P30CA006516-52 5399 Program 4: Leukemia EBERT, BENJAMIN BRIGHAM AND WOMEN'S HOSPITAL MA $43,922
Childhood Leukemia 2017 NCI 1R01CA211044-01 Off-the-shelf engineered NK cells for the treatment of AML REZVANI, KATY UNIVERSITY OF TX MD ANDERSON CAN CTR TX $366,000
Childhood Leukemia 2017 NCI 5R01CA164024-05 Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML HORTON, TERZAH BAYLOR COLLEGE OF MEDICINE TX $319,474
Childhood Leukemia 2017 NCI 5F31CA192822-03 Differential Regulation of PI3KC2beta by Ras Protooncogenes In Acute Myeloid Leukemia SMITH, RUSSELL UNIVERSITY OF ILLINOIS AT CHICAGO IL $23,996
Childhood Leukemia 2017 NCI 1R01CA211614-01 Targeting TET1 signaling to treat acute myeloid leukemia CHEN, JIANJUN UNIVERSITY OF CINCINNATI OH $430,865
Childhood Leukemia 2017 NHLBI 5R01HL117737-18 Microchimerism as AlloImmunity NELSON, J. FRED HUTCHINSON CANCER RESEARCH CENTER WA $477,844
Childhood Leukemia 2017 NCI 1R01CA211963-01 Ionizing radiation induced hematological malignancies ZHOU, DAOHONG UNIV OF ARKANSAS FOR MED SCIS AR $355,340
Childhood Leukemia 2017 NCI 1R01CA211711-01 APPLYING ERROR-CORRECTED SEQUENCING TO DETECT MINIMAL RESIDUAL IN THE AAML 1031 STUDY DRULEY, TODD WASHINGTON UNIVERSITY MO $388,615
Childhood Leukemia 2017 NCI 1R01CA212649-01 Personalized vaccine for patients with AML AVIGAN, DAVID BETH ISRAEL DEACONESS MEDICAL CENTER MA $739,429
Childhood Leukemia 2017 NCI 1R01CA211996-01 Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy CHOW, ERIC FRED HUTCHINSON CANCER RESEARCH CENTER WA $742,626
Childhood Leukemia 2017 NCI 1R01CA213131-01 Targeting Transcriptional Regulators for Immunotherapy of Acute Myeloid Leukemia KORTYLEWSKI, MARCIN BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $428,441
Childhood Leukemia 2017 NCI 1R01CA213138-01 CD25-mediated feedback control of BCR-signaling and its oncogenic mimics MÜSCHEN, MARKUS BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $395,738
Childhood Leukemia 2017 NCI 5R01CA192924-03 CSF2 receptor mediated actions in t(8;21) leukemia ZHANG, DONG-ER UNIVERSITY OF CALIFORNIA SAN DIEGO CA $343,706
Childhood Leukemia 2017 NCI 5R01CA142874-07 Targeting PML for Leukemia Therapy PANDOLFI, PIER PAOLO BETH ISRAEL DEACONESS MEDICAL CENTER MA $465,791
Childhood Leukemia 2017 NCI 5R01CA172040-05 Microenvironment-Leukemia Communication Through Lectins HEISTERKAMP, NORA CHILDREN'S HOSPITAL OF LOS ANGELES CA $336,150
Childhood Leukemia 2017 NHLBI 1K08HL135434-01 Targeting SETBP1 in Myeloproliferative Disorders STIEGLITZ, ELLIOT UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $179,928
Childhood Leukemia 2017 NCI 5F30CA186466-03 Role of GSK3beta Subcellular Localization in AML Stemness IGNATZ-HOOVER, JAMES CASE WESTERN RESERVE UNIVERSITY OH $29,040
Childhood Leukemia 2017 NCI 5R01CA166280-05 Therapeutic Targeting of Leukemia-Microenvironmental Interactions CALVI, LAURA UNIVERSITY OF ROCHESTER NY $318,513
Childhood Leukemia 2017 NCI 5P30CA021765-38 6702 Hematalogical Malignancies GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $695,188
Childhood Leukemia 2017 NCI 5P30CA021765-38 6709 Early Phase Clinical Research Support GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $256,191
Childhood Leukemia 2017 NCI 5P30CA021765-38 6716 Transdisciplinary Collaboration and Coordination GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $319,535
Childhood Leukemia 2017 NCI 5R01CA194057-03 Metabolic pathways in leukemia SCHUETZ, JOHN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $410,606
Childhood Leukemia 2017 NCI 5R01CA195642-03 Triad1 regulates myelopoiesis and functions as a leukemia suppressor EKLUND, ELIZABETH NORTHWESTERN UNIVERSITY AT CHICAGO IL $353,419
Childhood Leukemia 2017 NCI 5R01CA076167-14 Genetic Analysis of Myeloproliferative Disease COWELL, JOHN AUGUSTA UNIVERSITY GA $307,800
Childhood Leukemia 2017 NCI 5R01CA188520-03 Genome maintenance by Hdacs1,2 and their inhibition for Pre-B leukemia therapy BHASKARA, SRIVIDYA UNIVERSITY OF UTAH UT $340,838
Childhood Leukemia 2017 NCI 1R01CA204044-01A1 Regulation of TAL1/SCL in T-Cell Leukemia HUANG, SUMING UNIVERSITY OF FLORIDA FL $350,674
Childhood Leukemia 2017 NCI 5R01CA166429-06 Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia STEIDL, ULRICH ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $384,342
Childhood Leukemia 2017 NIGMS 1R01GM118578-01A1 Genetics-guided Individualization of Thiopurine Therapy YANG, JUN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $579,917
Childhood Leukemia 2017 NCI 5R01CA172387-05 Polysomy 21 in Acute Lymphoblastic Leukemia WEINSTOCK, DAVID DANA-FARBER CANCER INST MA $352,946
Childhood Leukemia 2017 NCI 5R01CA174793-05 BET bromodomain inhibition as targeted therapy in acute myeloid leukemia VAKOC, CHRISTOPHER COLD SPRING HARBOR LABORATORY NY $557,762
Childhood Leukemia 2017 NCI 5R01CA190843-03 A Label-Free, Point-of-Care Platform to Diagnose Acute Promyelocytic Leukemia SOHN, LYDIA UNIVERSITY OF CALIFORNIA BERKELEY CA $311,458
Childhood Leukemia 2017 NCI 1R01CA204979-01A1 Mechanisms of inv(16) acute myeloid leukemia CASTILLA, LUCIO UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $426,803
Childhood Leukemia 2017 NCI 2R01CA158073-06A1 The Role of ATM in Suppression of Lymphomas ZHA, SHAN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $380,000
Childhood Leukemia 2017 NCI 5R01CA193842-03 Characterizing MSI2 in leukemia KHARAS, MICHAEL SLOAN-KETTERING INST CAN RESEARCH NY $414,827
Childhood Leukemia 2017 NCI 5R01CA187004-03 Targeting MLL3 histone methyltransferase DOU, YALI UNIVERSITY OF MICHIGAN MI $354,563
Childhood Leukemia 2017 NCI 5R21CA205912-02 Mediator Kinases and AML Cell Proliferation TAATJES, DYLAN UNIVERSITY OF COLORADO CO $172,855
Childhood Leukemia 2017 NCI 5R01CA178454-05 The role and functional mechanism of TET1 in MLL-rearranged leukemia CHEN, JIANJUN UNIVERSITY OF CINCINNATI OH $327,850
Childhood Leukemia 2017 NCI 5R01CA163452-05 Novel lysine deacetylase 6 Hsp domain inhibitors against AML CHOU, CHUNG-JEN JAMES MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $310,213
Childhood Leukemia 2017 NCI 1K08CA201591-01A1 Targeting the ARHGAP25 pathway in acute myelogenous leukemia stem cells WANG, LEO BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $169,560
Childhood Leukemia 2017 NCI 5R01CA151898-07 CRLF2 signaling in B-cell acute lymphoblastic leukemia WEINSTOCK, DAVID DANA-FARBER CANCER INST MA $392,969
Childhood Leukemia 2017 NCI 5R01CA176091-05 Crenolanib and ponatinib for the treatment of FLT3 mutant AML SHAH, NEIL UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $328,888
Childhood Leukemia 2017 NCI 5R01CA201496-02 Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia ROSEN, STEVEN BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $463,530
Childhood Leukemia 2017 NICHD 1R21HD087760-01A1 Targeting SHP2 phosphatase for chemoprevention of leukemic progression in Noonan syndrome QU, CHENG-KUI EMORY UNIVERSITY GA $195,000
Childhood Leukemia 2017 NCI 5R01CA204308-02 Modulating signaling pathways in endothelial cells to abate leukemic progression. BUTLER, JASON WEILL MEDICAL COLL OF CORNELL UNIV NY $383,445
Childhood Leukemia 2017 NCI 5U01CA176063-04 ARID5B and disparities of childhood leukemia YANG, JUN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $368,510
Childhood Leukemia 2017 NCI 5R01CA193235-03 Metabolic Regulation in Leukemia-Initatiating Cells NAKADA, DAISUKE BAYLOR COLLEGE OF MEDICINE TX $462,191
Childhood Leukemia 2017 NCI 5R21CA197441-02 Unraveling the Function of RNA-Binding proteins in B-lympoblastic Leukemia RAO, DINESH UNIVERSITY OF CALIFORNIA LOS ANGELES CA $200,970
Childhood Leukemia 2017 NCI 5K99CA197498-03 Epigenetic mechanisms for oncogene silencing in MLL-rearranged leukemia CHEN, CHUN-WEI DANA-FARBER CANCER INST MA $154,058
Childhood Leukemia 2017 NCI 5R01CA171338-05 Novel Targeted Therapy for AML BHALLA, KAPIL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $332,000
Childhood Leukemia 2017 NCI 5UM1CA183730-04 Collaborative Human Tissue Network (CHTN) RAMIREZ, NILSA RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $774,914
Childhood Leukemia 2017 NCI 5R01CA190661-02 Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype STIREWALT, DEREK FRED HUTCHINSON CANCER RESEARCH CENTER WA $573,343
Childhood Leukemia 2017 NCI 5R21CA205936-02 SIRT5 as a Therapeutic Target in Acute Myeloid Leukemia DEININGER, MICHAEL UNIVERSITY OF UTAH UT $164,620
Childhood Leukemia 2017 NCI 5R21CA205644-02 (PQ11) Reversing exosome-mediated immune suppression - a novel strategy for cancer therapy WHITESIDE, THERESA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $202,439
Childhood Leukemia 2017 NCI 5R01CA206210-02 Therapeutic targeting of glutamine metabolism in MDS KONOPLEVA, MARINA UNIVERSITY OF TX MD ANDERSON CAN CTR TX $474,750
Childhood Leukemia 2017 NCI 5R01CA173852-04 Role of p21 activated kinase in Leukemogenesis KAPUR, REUBEN INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $323,700
Childhood Leukemia 2017 NCI 5R33CA191143-03 Single cell growth assay for residual cells in acute lymphoblastic leukemia MANALIS, SCOTT MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $450,496
Childhood Leukemia 2017 NCI 5K08CA204734-02 Determining the Role of BCOR Mutations in Myeloid Malignancies LINDSLEY, ROBERT DANA-FARBER CANCER INST MA $176,970
Childhood Leukemia 2017 NCI 1R41CA213690-01 AML-MutationCounter, a tool to detect residual and recurrent leukemia KAUFMANN, WILLIAM ASYSTBIO LABORATORIES, LLC NC $220,087
Childhood Leukemia 2017 NCI 1R44CA213595-01 Rapid detection of minimal residual disease in acute myeloid leukemia from peripheral blood MULLER, ROLF BIOFLUIDICA, INC NC $798,225
Childhood Leukemia 2017 NCI 5R01CA102031-12 Pharmacological modulation of epigenetic changes in AML MARCUCCI, GUIDO BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $342,107
Childhood Leukemia 2017 NCI 1F30CA213878-01 Co-Evolution of the CD8+ T Cell Repertoire and AML In the Setting of Immunotherapy GEORGE, JASON RICE UNIVERSITY TX $49,044
Childhood Leukemia 2017 NHLBI 1F31HL136107-01 Function of the Ubiquitin-Specific Peptidase 22 (USP22) in Acute Myeloid Leukemia MELO-CARDENAS, JOHANNA NORTHWESTERN UNIVERSITY AT CHICAGO IL $38,255
Childhood Leukemia 2017 NCI 5P01CA101937-14 7522 Genomics of AML Clonality LEY, TIMOTHY WASHINGTON UNIVERSITY MO $328,402
Childhood Leukemia 2017 NCI 5P01CA101937-14 7523 Genomics of AML Relapse DIPERSIO, JOHN WASHINGTON UNIVERSITY MO $330,341
Childhood Leukemia 2017 NCI 5P01CA101937-14 7524 Genomics of Familial MDS/AML GRAUBERT, TIMOTHY WASHINGTON UNIVERSITY MO $339,464
Childhood Leukemia 2017 NCI 5P01CA101937-14 7525 Genomics of Teatment-Related AML LINK, DANIEL WASHINGTON UNIVERSITY MO $334,581
Childhood Leukemia 2017 NCI 5P01CA101937-14 7526 Clinical Database WESTERVELT, PETER WASHINGTON UNIVERSITY MO $258,322
Childhood Leukemia 2017 NCI 5P01CA101937-14 7527 Specimen Acquisition, Genomic, Transcriptomic and Epigenetic Profilling PAYTON, JACQUELINE WASHINGTON UNIVERSITY MO $212,765
Childhood Leukemia 2017 NCI 5P01CA101937-14 7528 Sequencing and Integrated Analysis of AML Genomes WILSON, RICHARD WASHINGTON UNIVERSITY MO $986,260
Childhood Leukemia 2017 NCI 5P01CA101937-14 7529 Administration LEY, TIMOTHY WASHINGTON UNIVERSITY MO $127,287
Childhood Leukemia 2017 NCI 5R01CA176803-03 Targeted- and timed-releasing nanotherapeutics against leukemia stem cells PAN, CHONG-XIAN UNIVERSITY OF CALIFORNIA AT DAVIS CA $359,138
Childhood Leukemia 2017 NCI 5R01CA185062-04 (PQB3) CD4 T cell response to BCR-ABL-positive Leukemia FARRAR, MICHAEL UNIVERSITY OF MINNESOTA MN $312,304
Childhood Leukemia 2017 NIAID 1R21AI129426-01 Connecting Epigenetic Regulator MLL1 to ERK and Survival Signaling in B cells ERNST, PATRICIA UNIVERSITY OF COLORADO DENVER CO $228,355
Childhood Leukemia 2017 NHLBI 5R01HL131444-02 The role of EVI1-induced hypermethylation in leukemogenesis. QIAN, ZHIJIAN UNIVERSITY OF ILLINOIS AT CHICAGO IL $399,750
Childhood Leukemia 2017 NCI 5R01CA175353-04 Deep sequencing for minimal residual disease detection in Acute Lymphoblastic Leu ROBINS, HARLAN FRED HUTCHINSON CANCER RESEARCH CENTER WA $648,389
Childhood Leukemia 2017 NCI 5K08CA174750-04 Inhibiting STAT1 as a novel graft-versus-host/graft-versus-leukemia therapy CAPITINI, CHRISTIAN UNIVERSITY OF WISCONSIN-MADISON WI $178,740
Childhood Leukemia 2017 NCI 5F30CA196244-03 The role of the aryl hydrocarbon receptor in natural killer cell development in normal and acute myeloid leukemia donors SCOVILLE, STEVEN OHIO STATE UNIVERSITY OH $49,044
Childhood Leukemia 2017 NCI 5R01CA194923-03 Long non-coding RNAs in hematopoiesis and blood malignancy AIFANTIS, IANNIS NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $457,533
Childhood Leukemia 2017 NCI 5U54CA193419-03 7381 Project 2: Molecular Modulation of Chromatin and Nuclear Structure in Cancer LICHT, JONATHAN NORTHWESTERN UNIVERSITY AT CHICAGO IL $460,150
Childhood Leukemia 2017 NCI 5R01CA178030-04 Regulation of transcription and tumor suppression by MTG family members HIEBERT, SCOTT VANDERBILT UNIVERSITY TN $364,000
Childhood Leukemia 2017 NCI 5U54CA193461-03 7298 Project 1: Clonal Dynamics Guiding Curative Therapies for Acute Myeloid Leukemia SCADDEN, DAVID MASSACHUSETTS GENERAL HOSPITAL MA $532,795
Childhood Leukemia 2017 NCI 5K08CA184419-02 Chemotherapy resistance induced by SETD2 loss in leukemia MAR, BRENTON DANA-FARBER CANCER INST MA $177,120
Childhood Leukemia 2017 NCI 5R01CA190509-03 The function of cyclin C in tumorigenesis SICINSKI, PETER DANA-FARBER CANCER INST MA $453,569
Childhood Leukemia 2017 NHLBI 5R01HL115145-05 Yes1 as a quiescence regulator in hematopoietic stem cells MUKHERJEE, SIDDHARTHA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $400,000
Childhood Leukemia 2017 NCI 5K08CA181507-02 Analysis of TET2 function in acute leukemia SHIH, ALAN SLOAN-KETTERING INST CAN RESEARCH NY $180,036
Childhood Leukemia 2017 NCI 5R01CA175761-04 Function of the PR domain of the MDSI-EVI1 in MLL fusion protein leukemogenesis PERKINS, ARCHIBALD UNIVERSITY OF ROCHESTER NY $318,513
Childhood Leukemia 2017 NHLBI 5K08HL127269-03 Bone Marrow Microenvironmental Expression of Cytochrome P450 Enzymes GHIAUR, GABRIEL JOHNS HOPKINS UNIVERSITY MD $171,720
Childhood Leukemia 2017 NCI 5R01CA193776-03 Improving risk allocation and developing novel therapies for children with T-ALL TEACHEY, DAVID CHILDREN'S HOSP OF PHILADELPHIA PA $625,779
Childhood Leukemia 2017 NHLBI 5R01HL120724-03 Balanced signaling cues to guide cell transitions in the blood lineage continuum ROOSE, JEROEN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $742,879
Childhood Leukemia 2017 NCI 5R01CA194552-03 RETARGETING AGENTS TO TREAT AML DIPERSIO, JOHN WASHINGTON UNIVERSITY MO $380,068
Childhood Leukemia 2017 NCI 5R01CA197991-02 Determining the Role of Metabolism in Resistance in Acute Myeloid Leukemia PARDEE, TIMOTHY WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $354,563
Childhood Leukemia 2017 NCI 5R01CA173877-05 Targeted Therapy for AML Stem Cells BHALLA, KAPIL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $332,000
Childhood Leukemia 2017 NCI 5R01CA133379-09 The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia. AIFANTIS, IANNIS NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $381,375
Childhood Leukemia 2017 NCI 5R01CA132946-10 Pharmacogenomics of Ara-C in AML LAMBA, JATINDER UNIVERSITY OF FLORIDA FL $310,602
Childhood Leukemia 2017 NCI 5R01CA064140-24 Role of AML1-ETO in Acute Leukemia HIEBERT, SCOTT VANDERBILT UNIVERSITY TN $353,250
Childhood Leukemia 2017 NCI 5U10CA180886-04 COG NCTN Network Group Operations Center ADAMSON, PETER CHILDREN'S HOSP OF PHILADELPHIA PA $22,547,116
Childhood Leukemia 2017 NCI 5R01CA182284-05 Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats COLE, PETER ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $346,525
Childhood Leukemia 2017 NIGMS 5F31GM116569-02 Developing an Artemis Nuclease Inhibitor to Potentially Treat Acute Lymphoblastic Leukemia ESGUERRA, ZITADEL ANNE UNIVERSITY OF SOUTHERN CALIFORNIA CA $42,686
Childhood Leukemia 2017 NINDS 5R21NS095273-02 Modulating the Nucleopathy caused by FUS Mutants of ALS HAYWARD, LAWRENCE UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $209,375
Childhood Leukemia 2017 NCI 5R01CA178765-05 Transcriptional regulatory mechanisms in B cell development and leukemogenesis ROEDER, ROBERT ROCKEFELLER UNIVERSITY NY $565,455
Childhood Leukemia 2017 NCI 1U01CA214116-01 Proteogenomic Translational Research Center for Clinical Proteomic RODLAND, KARIN BATTELLE PACIFIC NORTHWEST LABORATORIES WA $1,374,609
Childhood Leukemia 2017 NCI 5R25CA183725-03 Problem-Solving Skills Training for Clinicians Providing Psychosocial Care in Pediatric Oncology SAHLER, OLLE JANE UNIVERSITY OF ROCHESTER NY $301,523
Childhood Leukemia 2017 NCI 5R01CA098571-13 Molecular Mechanisms of eIF4E mediated transformation BORDEN, KATHERINE UNIVERSITY OF MONTREAL CANADA $256,369
Childhood Leukemia 2017 NCI 5R01CA090321-15 Role of Sialic Acid Modification in ALL Survival and Drug Resistance HEISTERKAMP, NORA CHILDREN'S HOSPITAL OF LOS ANGELES CA $266,069
Childhood Leukemia 2017 NCI 5R00CA168996-05 The role of Jmjd1c in normal and leukemic hematopoiesis ZHU, NAN BLOODCENTER OF WISCONSIN, INC. WI $238,701
Childhood Leukemia 2017 NCI 5R01CA188269-04 Developing CRM1 inhibitors in AML GARZON, RAMIRO OHIO STATE UNIVERSITY OH $319,550
Childhood Leukemia 2017 NCI 5R01CA185058-04 Impact of low IL-10 levels at birth and leukemia risk WIEMELS, JOSEPH UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $606,390
Childhood Leukemia 2017 NCI 5F31CA203161-02 Targeting PARP and RAD52 to induce "dual synthetic lethality" in leukemia patients identified by gene expression and mutation profiling SULLIVAN, KATHERINE TEMPLE UNIV OF THE COMMONWEALTH PA $29,663
Childhood Leukemia 2017 NCI 5R01CA172896-05 Investigating the mechanism of ITGA4/6-mediated chemoprotection of ALL cells KIM, YONG-MI CHILDREN'S HOSPITAL OF LOS ANGELES CA $335,154
Childhood Leukemia 2017 NCI 5R01CA173085-05 Mechanisms linking RAS signals to disordered hematopoiesis and myeloid neoplasia BRAUN, BENJAMIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $328,888
Childhood Leukemia 2017 NCI 2P30CA006973-54 8084 Hematologic Malignancies and BMT Program - 02 AMBINDER, RICHARD JOHNS HOPKINS UNIVERSITY MD $55,302
Childhood Leukemia 2017 NCI 1P01CA214278-01 8888 Project 1: Overcoming resistance of B cell leukemia to CD19 CAR T Cells. PORTER, DAVID UNIVERSITY OF PENNSYLVANIA PA $435,992
Childhood Leukemia 2017 NCI 1P01CA214278-01 5000 Project 2: Towards a safe and effective AML treatment strategy using anti-CD33 CAR T cells in combination with CAR-resistant hematopoietic stem cells GILL, SAAR UNIVERSITY OF PENNSYLVANIA PA $266,231
Childhood Leukemia 2017 NCI 5R21CA205828-02 Examining the role of normal hematopoiesis in supporting incipient myelodysplasia PERKINS, ARCHIBALD UNIVERSITY OF ROCHESTER NY $167,475
Childhood Leukemia 2017 NCI 5K08CA166229-05 HISTONE H3 METHYLATION AND EPIGENOMICS IN ACUTE LEUKEMIA WARTMAN, LUKAS WASHINGTON UNIVERSITY MO $153,699
Childhood Leukemia 2017 NCI 5R01CA185687-03 Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging SMITH-BINDMAN, REBECCA UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $2,177,040
Childhood Leukemia 2017 NCI 5P30CA013696-43 6105 Lymphoid Development and Malignancy Program EMERSON, STEPHEN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $35,133
Childhood Leukemia 2017 NCI 5P30CA013696-43 6127 Recruitment EMERSON, STEPHEN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $95,447
Childhood Leukemia 2017 NCI 5K08CA191091-03 Epigenetic mechanisms of drug resistance in T-cell acute lymphoblastic leukemia KNOECHEL, BIRGIT DANA-FARBER CANCER INST MA $177,120
Childhood Leukemia 2017 NCI 5R01CA175215-05 Single-Cell Methods for Analysis of Clonal Heterogeneity and Evolution in Cancer RADICH, JERALD FRED HUTCHINSON CANCER RESEARCH CENTER WA $579,042
Childhood Leukemia 2017 NCI 1R01CA214965-01 The role and mechanism of FTO in leukemogenesis and drug response CHEN, JIANJUN UNIVERSITY OF CINCINNATI OH $412,442
Childhood Leukemia 2017 NCI 5R01CA201069-02 Pathway Specific Combinational Therapy in Poor Prognosis B-Lineage Acute Lymphoblastic Leukemia OPFERMAN, JOSEPH ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $410,606
Childhood Leukemia 2017 NCI 1R56CA215059-01 The Role of DLST in Leukemogenesis FENG, HUI BOSTON UNIVERSITY MEDICAL CAMPUS MA $376,294
Childhood Leukemia 2017 NCI 5R01CA190261-03 The impact of chromosome 17p lesions on leukemogeneis and therapy response LOWE, SCOTT SLOAN-KETTERING INST CAN RESEARCH NY $402,371
Childhood Leukemia 2017 NHLBI 1R01HL136504-01 TEMPORAL CHANGES IN MECHANISMS OF HSC SELF-RENEWAL AND MYELOID LEUKEMOGENESIS MAGEE, JEFFREY WASHINGTON UNIVERSITY MO $381,250
Childhood Leukemia 2017 NCI 1R01CA215504-01 Instructive role of MLL fusion proteins in lineage determination and leukemogenesis THIRMAN, MICHAEL UNIVERSITY OF CHICAGO IL $609,178
Childhood Leukemia 2017 NCI 5K08CA190815-03 REGULATORY MECHANISMS OF HOX GENE EXPRESSION IN ACUTE MYELOID LEUKEMIA SPENCER, DAVID WASHINGTON UNIVERSITY MO $166,298
Childhood Leukemia 2017 NCI 5R01CA057138-26 Employing the Myc Transcriptional Network to Reveal Oncogenic Pathways EISENMAN, ROBERT FRED HUTCHINSON CANCER RESEARCH CENTER WA $635,460
Childhood Leukemia 2017 NCI 5U01CA199000-03 Pediatric Preclinical Testing Consortium - Leukemia LOCK, RICHARD UNIVERSITY OF NEW SOUTH WALES AUSTRA $390,171
Childhood Leukemia 2017 NCI 5R01CA163926-05 Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia GREEN, MICHAEL UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $347,563
Childhood Leukemia 2017 NCI 5R01CA036401-34 Pharmacogenomics of Childhood Leukemia ALL EVANS, WILLIAM ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $726,540
Childhood Leukemia 2017 NCI 5R21CA201831-02 SFK-inhibitor enhancement of ATRA-mediated differentiation of APL REDNER, ROBERT UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $169,106
Childhood Leukemia 2017 NHLBI 1K08HL136894-01 Hedgehog Signaling in the Progression of Myelodysplastic Syndromes GONDEK, LUKASZ JOHNS HOPKINS UNIVERSITY MD $171,720
Childhood Leukemia 2017 NCI 5K08CA169485-05 Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W CHAPUIS, AUDE FRED HUTCHINSON CANCER RESEARCH CENTER WA $171,372
Childhood Leukemia 2017 NCI 5R01CA198089-03 Understanding and Targeting Chemotherapy Resistance in Acute Myeloid Leukemia CARROLL, MARTIN UNIVERSITY OF PENNSYLVANIA PA $663,135
Childhood Leukemia 2017 NCI 5K08CA194256-03 Chimeric Antigen Receptor T cell Therapy for Acute Myeloid Leukemia (AML) GILL, SAAR UNIVERSITY OF PENNSYLVANIA PA $167,832
Childhood Leukemia 2017 NCI 5R21CA201775-02 Targeting B cell activating factor receptor (BAFF-R) as a novel therapeutic strategy for drug resistant Acute Lymphoblastic Leukemia (ALL) PARAMESWARAN, RESHMI CASE WESTERN RESERVE UNIVERSITY OH $172,369
Childhood Leukemia 2017 NCI 5R01CA187318-03 Molecular understanding of cytokine-Ras signals in leukemic bone marrow ROOSE, JEROEN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $353,777
Childhood Leukemia 2017 NCI 5R01CA189074-03 Small molecule CXCR4 modulators as molecular probes for studying AML SCHILTZ, GARY NORTHWESTERN UNIVERSITY IL $513,581
Childhood Leukemia 2017 NCI 2K12CA090433-16 Pediatric Oncology Clinical Research Training Program POPLACK, DAVID BAYLOR COLLEGE OF MEDICINE TX $810,000
Childhood Leukemia 2017 NCI 5R01CA104509-13 Molecular Mechanism of Leukemogenesis Involving AML1-ETO ZHANG, DONG-ER UNIVERSITY OF CALIFORNIA SAN DIEGO CA $331,313
Childhood Leukemia 2017 NCI 5R35CA197561-03 Molecular Pathogenesis of Acute Myeloid Leukemia LEY, TIMOTHY WASHINGTON UNIVERSITY MO $915,000
Childhood Leukemia 2017 NCI 5R01CA193478-02 Web-based Physical Activity Intervention for Children with ALL NESS, KIRSTEN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $869,905
Childhood Leukemia 2017 NCI 5R01CA209829-02 Targeting CRLF2 and Ikaros Alterations to Reduce Health Disparities in Childhood Leukemia PAYNE, KIMBERLY LOMA LINDA UNIVERSITY CA $360,547
Childhood Leukemia 2017 NCI 5F30CA203292-02 Chromatin dysregulation generated by recurrent point mutation in histone methyltransferase, MMSET, drives progression of lymphoid malignancies SWAROOP, ALOK UNIVERSITY OF FLORIDA FL $38,371
Childhood Leukemia 2017 NCI 5R21CA202488-02 Unlocking the Therapeutic Potential of Retinoic Acid in Acute Myeloid Leukemia SWORDS, RONAN UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $166,931
Childhood Leukemia 2017 NIGMS 5P50GM115279-03 7544 CPML - Core A: Administrative Core RELLING, MARY ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $204,478
Childhood Leukemia 2017 NIGMS 5P50GM115279-03 7545 CPML - Core B: Cell & Molecular Core CREWS, KRISTINE ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $348,034
Childhood Leukemia 2017 NIGMS 5P50GM115279-03 7546 CPML - Core C: Bioinformatics & Biostatistical Core ZHANG, JINGHUI ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $596,871
Childhood Leukemia 2017 NIGMS 5P50GM115279-03 7547 CPML - Project 1: Genome-wide Studies of ALL Response MULLIGHAN, CHARLES ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $737,381
Childhood Leukemia 2017 NIGMS 5P50GM115279-03 7548 CPML - Project 2: Genome-wide Studies of ALL Drug Sensitivity EVANS, WILLIAM ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $707,707
Childhood Leukemia 2017 NIGMS 5P50GM115279-03 7549 CPML - Project 3: Genome-wide Studies of Adverse Effects RELLING, MARY ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $369,780
Childhood Leukemia 2017 NCI 5P30CA125123-11 8015 Pediatric Cancer Program (Project-007) POPLACK, DAVID BAYLOR COLLEGE OF MEDICINE TX $43,684
Childhood Leukemia 2017 NCI 5R21CA202296-02 HSC-Independent Mechanisms Underlying JMML KAPUR, REUBEN INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $205,538
Childhood Leukemia 2017 NCI 1R01CA216421-01 The cohesin complex as a tumor suppressor in myeloid leukemia AIFANTIS, IANNIS NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $536,993
Childhood Leukemia 2017 NCI 1R01CA207086-01A1 Mechanisms of KLF4 suppression in pediatric leukemia LACORAZZA, DANIEL BAYLOR COLLEGE OF MEDICINE TX $326,540
Childhood Leukemia 2017 NCI 1R01CA216352-01 In Vivo Functional Analysis of Chromosome 7q22 Deletions in Myeloid Malignancies SHANNON, KEVIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $338,672
Childhood Leukemia 2017 NCI 5R03CA186176-02 Targeting high fat diet-driven DNA hypermethylation for AML chemoprevention LIU, SHUJUN UNIVERSITY OF MINNESOTA MN $77,500
Childhood Leukemia 2017 NCI 5R01CA172443-04 Targeting NEDD8-Mediated Protein Turnover in AML CAREW, JENNIFER UNIVERSITY OF ARIZONA AZ $286,661
Childhood Leukemia 2017 NCI 5R21CA202390-02 PRMT1-mediated metabolic reprogramming in leukemia progression ZHAO, XINYANG UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $191,835
Childhood Leukemia 2017 NHLBI 1R01HL132921-01A1 Mitotic failure in Fanconi anemia: mechanisms and role in carcinogenesis NALEPA, GRZEGORZ INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $393,750
Childhood Leukemia 2017 NCI 2R01CA101774-15 Mechanisms of Leukemogenesis in Down Syndrome CRISPINO, JOHN NORTHWESTERN UNIVERSITY AT CHICAGO IL $336,656
Childhood Leukemia 2017 NCI 1R01CA201235-01A1 Targeting the GFI1-LSD1 Axis in T-Cell Acute Lymphoblastic Leukemia ENGEL, MICHAEL UNIVERSITY OF UTAH UT $346,271
Childhood Leukemia 2017 NCI 5R01CA096899-12 Mechanism(s) of TAL1-and NOTCH1-mediated Leukemogenesis KELLIHER, MICHELLE UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $358,031
Childhood Leukemia 2017 NCI 5F31CA206322-02 Mechanism of the methyltransferase Prdm3 in MLL leukemogenesis MCGLYNN, KELLY UNIVERSITY OF ROCHESTER NY $44,044
Childhood Leukemia 2017 NCI 5R21CA209229-02 Mechanism of Ikaros Tumor Suppression in progenitor B cell leukemia SCHJERVEN, HILDE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $184,753
Childhood Leukemia 2017 NCI 5F31CA196045-03 The role of PRDM16 in Leukemia CORRIGAN, DAVID COLUMBIA UNIVERSITY HEALTH SCIENCES NY $41,070
Childhood Leukemia 2017 NCI 1K08CA201611-01A1 DEFINING THE ROLE OF DOT1L IN DNMT3A-MUTANT LEUKEMIA RAU, RACHEL BAYLOR COLLEGE OF MEDICINE TX $162,148
Childhood Leukemia 2017 NCI 5R01CA196658-02 A rapid spontaneous murine model of CN-AML GRIMES, H. CINCINNATI CHILDRENS HOSP MED CTR OH $575,500
Childhood Leukemia 2017 NCI 1K99CA207731-01A1 Discovery of Synthetic Lethal Targets for Recurrent Epigenetic Mutations in Acute Myeloid Leukemia THOMAS, DANIEL STANFORD UNIVERSITY CA $173,448
Childhood Leukemia 2017 NCI 1K08CA201640-01A1 Developing differentiation therapy for the treatment of patients with acute myeloid leukemia SYKES, DAVID MASSACHUSETTS GENERAL HOSPITAL MA $169,268
Childhood Leukemia 2017 NCI 5R01CA187903-03 CHARACTERIZATION OF THE MOLECULAR INTERPLAY BETWEEN HOXA9 AND OGT IN ACUTE LEUKEMIA RUAL, JEAN-FRANCOIS UNIVERSITY OF MICHIGAN MI $354,563
Childhood Leukemia 2017 NCI 7R01CA201444-02 Adipocytes are Important Players in the Acute Lymphoblastic Leukemia Microenvironment MITTELMAN, STEVEN UNIVERSITY OF CALIFORNIA LOS ANGELES CA $396,181
Childhood Leukemia 2017 NCI 1R21CA216551-01 Targeting DNA Base Excision Repair in Acute Myeloid Leukemias LLOYD, R. OREGON HEALTH & SCIENCE UNIVERSITY OR $200,970
Childhood Leukemia 2017 NCI 5R01CA196604-03 Direct coregulation of Notch1 by Zmiz1 in T-cell leukemia CHIANG, MARK UNIVERSITY OF MICHIGAN MI $354,563
Childhood Leukemia 2017 NCI 5R01CA187397-04 Exercise and QUality diet After Leukemia TONOREZOS, EMILY SLOAN-KETTERING INST CAN RESEARCH NY $621,296
Childhood Leukemia 2017 NCI 1R01CA204231-01A1 Cohesin Mutations in Acute Myelogenous Leukemia RAO, SRIDHAR BLOODCENTER OF WISCONSIN, INC. WI $391,588
Childhood Leukemia 2017 NCI 5R01CA175026-04 Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML REDELL, MICHELE BAYLOR COLLEGE OF MEDICINE TX $379,294
Childhood Leukemia 2017 NCI 5R01CA175737-04 Perinatal immune development and risk of childhood acute lymphoblastic leukemia WIEMELS, JOSEPH UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $675,204
Childhood Leukemia 2017 NCI 1R21CA208937-01A1 Mechanism-based approach to combine histone deacetylase inhibitors with PARP inhibitors for therapy in AML RASSOOL, FEYRUZ UNIVERSITY OF MARYLAND BALTIMORE MD $201,459
Childhood Leukemia 2017 NCI 5R00CA188293-04 Exploring a new therapeutic approach through targeting epigenetic enzymes in ALL NTZIACHRISTOS, PANAGIOTIS NORTHWESTERN UNIVERSITY AT CHICAGO IL $249,000
Childhood Leukemia 2017 NCI 5F31CA206338-02 Myc transcriptional regulation in T-ALL FORSYTH, KATHERINE UNIVERSITY OF PENNSYLVANIA PA $44,044
Childhood Leukemia 2017 NCI 5U01CA183030-04 Therapeutic Elimination of Stem Cells for Relapsed Pediatric AML LIU, YANG CHILDREN'S RESEARCH INSTITUTE DC $521,464
Childhood Leukemia 2017 RMAP 5K01ES026842-03 Connecting Single Cell Heterogeneity to Clinical Descriptors of Clonal Evolution in Acute Myeloid Leukemia PAGUIRIGAN, AMY FRED HUTCHINSON CANCER RESEARCH CENTER WA $119,735
Childhood Leukemia 2017 NCI 5R01CA176624-04 Tsc1/mTOR axis in immune homeostasis and tumorigenesis CHI, HONGBO ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $372,463
Childhood Leukemia 2017 NHLBI 5R01HL128173-03 Multiscale Modeling of Myelodysplastic Syndromes COREY, SETH VIRGINIA COMMONWEALTH UNIVERSITY VA $729,676
Childhood Leukemia 2017 NCI 5R01CA193651-03 Discovery and targeting of apoptosis resistance mechanisms in high-risk T-ALL GUTIERREZ, ALEJANDRO BOSTON CHILDREN'S HOSPITAL MA $446,954
Childhood Leukemia 2017 NCI 5F31CA206463-02 Clonal Progression of Cancer Cells during Treatment of Acute Lymphoblastic Leukemia CONTRERAS-TRUJILLO, HUMBERTO UNIVERSITY OF SOUTHERN CALIFORNIA CA $43,477
Childhood Leukemia 2017 NCI 5R00CA184411-05 Research career advancement: Role of the SIRT1 deacetylase in maintenance of FLT3 LI, LING BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $248,999
Childhood Leukemia 2017 NCI 5K01CA188151-03 Targeted Alpha Radioimmunotherapy with Haploidentical Bone Marrow Transplantation for AML OROZCO, JOHNNIE FRED HUTCHINSON CANCER RESEARCH CENTER WA $169,020
Childhood Leukemia 2017 NCI 5R00CA181488-04 The Role of EglN1 and HIF in Normal Hematopoiesis and in Leukemia LOSMAN, JULIE DANA-FARBER CANCER INST MA $249,000
Childhood Leukemia 2017 NCI 5K08CA187577-04 Investigating Resistance to FLT3 Inhibitors in AML SMITH, CATHERINE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $175,808
Childhood Leukemia 2017 NCI 5F30CA210518-02 Evaluation of Bruton’s Tyrosine Kinase and p110 delta in Mutant Shp2-Induced JMML DENG, LISA INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $36,469
Childhood Leukemia 2017 NCI 5P50CA100632-15 SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia KANTARJIAN, HAGOP UNIVERSITY OF TX MD ANDERSON CAN CTR TX $2,300,000
Childhood Leukemia 2017 NHLBI 5R01HL130995-02 Germline mutations of PTPN11 (SHP-2) in the stem cell microenvironment QU, CHENG-KUI EMORY UNIVERSITY GA $390,000
Childhood Leukemia 2017 NCI 1F30CA217006-01 Analysis of the novel phenomenon of antibody-mediated fratricide in Acute Myeloid Leukemia FATEHCHAND, KAVIN OHIO STATE UNIVERSITY OH $39,139
Childhood Leukemia 2017 NCI 5K08CA188529-04 Genomic profiling and development of murine models of transformation of MPNs RAMPAL, RAAJIT SLOAN-KETTERING INST CAN RESEARCH NY $178,200
Childhood Leukemia 2017 NCI 5R35CA210030-02 Integrating Transforming Approaches to Identify and Target New Vulnerabilities in Cancer STEGMAIER, KIMBERLY DANA-FARBER CANCER INST MA $1,046,441
Childhood Leukemia 2017 NCI 1F30CA217027-01 Investigating the role of miR-155 and the interferon response in FLT3-ITD+ AML WALLACE, JARED UNIVERSITY OF UTAH UT $40,644
Childhood Leukemia 2017 NCI 1F31CA216976-01 The Effect Of Cohesin Mutations In Hematologic Malignancies MCNULTY, MAUREEN NORTHWESTERN UNIVERSITY AT CHICAGO IL $38,129
Childhood Leukemia 2017 NCI 5R01CA140729-07 Drug resistant pathways in relapsed acute lymphoblastic leukemia (ALL) CARROLL, WILLIAM NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $454,699
Childhood Leukemia 2017 NIAMS 5R01AR054447-10 The Osteoblast as a Determinant of Leukemogenesis KOUSTENI, STAVROULA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $341,711
Childhood Leukemia 2017 NCI 5R01CA138744-08 Tyrosine kinase inhibitors for the treatment of childhood AML BAKER, SHARYN OHIO STATE UNIVERSITY OH $343,388
Childhood Leukemia 2017 NCI 5R01CA195732-02 The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy LICHT, JONATHAN UNIVERSITY OF FLORIDA FL $348,844
Childhood Leukemia 2017 NCI 1R01CA217092-01 Mechanisms of Formation and Progression of Preleukemic Stem Cells STEIDL, ULRICH ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $397,371
Childhood Leukemia 2017 NIEHS 5P50ES018172-08 5328 Core A - Administrative Core METAYER, CATHERINE UNIVERSITY OF CALIFORNIA BERKELEY CA $170,439
Childhood Leukemia 2017 NIEHS 5P50ES018172-08 5329 Project 1 - In Utero Chemical Exposures, Immune Status, and Childhood Leukemia METAYER, CATHERINE UNIVERSITY OF CALIFORNIA BERKELEY CA $184,021
Childhood Leukemia 2017 NIEHS 5P50ES018172-08 5330 Project 2 - Identifying In Utero Exposures that are Risk Factors for Childhood Leukemia RAPPAPORT, STEPHEN UNIVERSITY OF CALIFORNIA BERKELEY CA $176,369
Childhood Leukemia 2017 NIEHS 5P50ES018172-08 5331 Project 3 - Prenatal Exposures, Constitutive Genetics, DNA Methylation & Childhood Leukemia WIEMELS, JOSEPH UNIVERSITY OF CALIFORNIA BERKELEY CA $168,610
Childhood Leukemia 2017 NIEHS 5P50ES018172-08 5332 Core B - Community Outreach and Translation Core MILLER, MARK UNIVERSITY OF CALIFORNIA BERKELEY CA $87,541
Childhood Leukemia 2017 NIEHS 5P50ES018172-08 5333 Core C - Mouse Model Service Core KOGAN, SCOTT UNIVERSITY OF CALIFORNIA BERKELEY CA $63,020
Childhood Leukemia 2017 NCI 5F31CA192885-03 The Role of DDX41 in the Spliceosome and Myeloid Neoplasia HIZNAY, JAMES CLEVELAND CLINIC LERNER COM-CWRU OH $38,328
Childhood Leukemia 2017 NCI 1F31CA217140-01 Novel mechanisms and therapeutic strategies of refractory leukemia MELGAR, KATELYN CINCINNATI CHILDRENS HOSP MED CTR OH $36,724
Childhood Leukemia 2017 NCI 5F32CA203049-02 Targeting PRL2 phosphatase in acute myeloid leukemia NABINGER, SARAH INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $64,245
Childhood Leukemia 2017 NCI 5K08CA184418-04 PI3K Pathway Inhibition for Philadelphia-Like Acute Lymphoblastic Leukemia TASIAN, SARAH CHILDREN'S HOSP OF PHILADELPHIA PA $169,657
Childhood Leukemia 2017 NCI 5R01CA181024-04 Prevention of bone loss after pediatric hematopoietic cell transplantation SARAFOGLOU, KYRIAKIE UNIVERSITY OF MINNESOTA MN $1
12


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer